IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—21 January 2014

12:25 AM MST | January 21, 2014 | Deepti Ramesh

Feature Antibody-drug conjugates: A developing market with substantial growth potential The antibody-drug conjugates (ADCs) market, which is in its early stages of development, offers growth opportunities for several contract-manufacturing organizations (CMOs). With the success of two ADC drug products in the worldwide market, and with several others in different stages of development, CMOs are looking to ride the growth wave, experts and industry players say. ADCs are a mix of synthetic chemistry and biopharmaceuticals, says Enrico Polastro, v.p. and senior...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa